Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma
Clinical trial NCT05527795 · RECRUITING
Trial details
- NCT number
- NCT05527795
- Sponsor
- Hospices Civils de Lyon
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-01
- Primary completion
- 2029-01-01
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.